In vitro activity of BRL 36650, a new penicillin (original) (raw)

Comparative Activities of the Oxa- -Lactam LY127935, Cefotaxime, Cefoperazone, Cefamandole, and Ticarcillin Against Multiply Resistant Gram-Negative Bacilli

Dale Gerding

Antimicrobial Agents and Chemotherapy, 1980

View PDFchevron_right

Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18 569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997–2001)

Ronald Jones

International Journal of Antimicrobial Agents, 2003

View PDFchevron_right

Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations

Ellie Goldstein

Antimicrobial Agents and Chemotherapy, 1991

View PDFchevron_right

Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria

manuel borobio

Antimicrobial Agents and Chemotherapy, 1980

View PDFchevron_right

Comparative in vitro activities of azlocillin-cefotaxime and azlocillin-tobramycin combinations against blood and multi-drug resistant bacterial isolates

Hjalmar Lagast

Antimicrobial Agents and Chemotherapy, 1982

View PDFchevron_right

Evaluation of Microbiological Assays of Antibiotics

Sheetal Arya

View PDFchevron_right

In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics

Dale Gerding

Antimicrobial Agents and Chemotherapy, 1984

View PDFchevron_right

Evaluation of In vitro Activity of Cefiderocol and Ceftolozane-Tazobactam against Extended-Spectrum β-Lactamase–Producing Coliform and Multidrug Resistant Acinetobacter baumannii and Pseudomonas aeruginosa

sarah shoeib

Egyptian Journal of Medical Microbiology

View PDFchevron_right

In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic

Johan Boelaert

Antimicrobial Agents and Chemotherapy, 1982

View PDFchevron_right

Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan

Dilip Mathai

Diagnostic Microbiology and Infectious Disease, 1999

View PDFchevron_right

Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes

Fernando Baquero

Antimicrobial agents and chemotherapy, 1999

View PDFchevron_right

In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives

Claudia Carrilho, Inneke Marie van der Heijden, Anna Levin

Journal of Infection and Chemotherapy, 2015

View PDFchevron_right

Correlation of in vitro susceptibility testing results for amoxicillin-clavulanate and ampicillin-sulbactam using a panel of β-lactamase-producing Enterobacteriaceae

Kris Siu

APMIS, 1998

View PDFchevron_right

Multilaboratory evaluation of the in vitro activity of 13 β-lactam antibiotics against 1474 clinical isolates of aerobic and anaerobic bacteria

M Erwin

Diagnostic Microbiology and Infectious Disease, 1993

View PDFchevron_right

Antibiotic Coresistance in Extended-Spectrum- -Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline

Teresa Coque

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

In vitro activity of ME1036 versus other -lactams against penicillin-resistant Streptococcus pneumoniae serotypes exhibiting higher amoxicillin than penicillin MIC

María-José Giménez

Journal of Antimicrobial Chemotherapy, 2008

View PDFchevron_right

Antibacterial Action of "Broad-Spectrum" Penicillins, Cephalosporins and Other Antibiotics Against Gram-Negative Bacilli Isolated from Bacteremic Patients

Charles McCall

Annals of the New York Academy of Sciences, 1967

View PDFchevron_right

Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems

Miguel Ángel Moreno

Enfermedades Infecciosas y Microbiología Clínica, 2019

View PDFchevron_right

Chapter e1: Anti-Infective Chemotherapeutic & Antibiotic Agents

Christian Pereira

View PDFchevron_right

Comparative in vitro activities of seven new beta-lactams, alone and in combination with beta-lactamase inhibitors, against clinical isolates resistant to third generation cephalosporins

Varsha Gupta

Brazilian Journal of Infectious Diseases, 2006

View PDFchevron_right

Comparison of antibiotic resistance of gram-negative bacilli with β-lactam and aminoglycoside antibiotics

henri dabernat

Diagnostic Microbiology and Infectious Disease, 1986

View PDFchevron_right

Screening Antimicrobial Susceptibility of Gentamicin, Vancomycin, Azithromycin, Chloramphenicol and Cefotaxime Against Selected Gram Positive and Gram Negative Bacteria

International Journal of Pharma Research and Health Sciences

International Journal of Pharma Research and Health Sciences, 2014

View PDFchevron_right

Comparison of the Antibacterial Activities of Different Antibiotics Against Clinical Isolates

sarosh malik

Pakistan BioMedical Journal, 2022

View PDFchevron_right

Activity of ceftazidime–avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance

Noemí Alonso

Enfermedades Infecciosas y Microbiología Clínica, 2017

View PDFchevron_right

Activity of selected β-lactams, ciprofloxacin, and amikacin against different Acinetobacter baumannii biotypes from chilean hospitals

Mariana Domínguez

Diagnostic Microbiology and Infectious Disease, 1997

View PDFchevron_right

Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia

M Carmen Conejo

Journal of Antimicrobial Chemotherapy

View PDFchevron_right

Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin

Joel Ward

Antimicrobial Agents and Chemotherapy, 1981

View PDFchevron_right

Study of the comparative activity of piperacillin/tazobactam with currently available antibiotics against 8206 aerobic isolates

Robert Rennie

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 1997

View PDFchevron_right

Avaliação da resistência a antibióticos de bactérias isoladas de efluente hospitalar

Célia Regina Granhen Tavares

Acta Scientiarum. Technology, 2010

View PDFchevron_right

Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group

Ellie Goldstein

Antimicrobial Agents and Chemotherapy, 1991

View PDFchevron_right

Patrón de sensibilidad a antibióticos de bacterias Gram negativas aisladas a partir de fórmulas enterales

Rafael Monge-Rojas

REVISTA BIOMÉDICA, 2000

View PDFchevron_right

Detection of extended broad-spectrum beta-lactamases inEnterobacteriaceae in four French hospitals

Dominique Decré

European Journal of Clinical Microbiology & Infectious Diseases, 1989

View PDFchevron_right

In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria

Fu-der Wang

International journal of antimicrobial agents, 2004

View PDFchevron_right

Sensitivity pattern of Gram negative bacteria to the new β-lactam/ β-lactamase inhibitor combination: Cefepime/tazobactam

ABDUL GHAFUR

Journal of Microbiology and Infectious Diseases, 2012

View PDFchevron_right

In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance

Luigi M Lapalorcia

The Open Microbiology Journal, 2008

View PDFchevron_right